scholarly journals A phase I study of daily afatinib, an irreversible ErbB family blocker, in combination with weekly paclitaxel in patients with advanced solid tumours

2015 ◽  
Vol 51 (16) ◽  
pp. 2275-2284 ◽  
Author(s):  
A. Suder ◽  
J.E. Ang ◽  
F. Kyle ◽  
D. Harris ◽  
S. Rudman ◽  
...  
2012 ◽  
Vol 23 ◽  
pp. ix161
Author(s):  
D. Enting ◽  
J.E. Ang ◽  
C. O'Hanlon-Brown ◽  
R. Kristeleit ◽  
M. Uttenreuther-Fischer ◽  
...  

2008 ◽  
Vol 44 (13) ◽  
pp. 1829-1834 ◽  
Author(s):  
S. Cresta ◽  
C. Sessa ◽  
C.V. Catapano ◽  
E. Gallerani ◽  
D. Passalacqua ◽  
...  

2001 ◽  
Vol 37 ◽  
pp. S75
Author(s):  
N. Androulakis ◽  
Ch. Kouroussis ◽  
D. Mavroudis ◽  
S. Agelaki ◽  
J. Souglakos ◽  
...  

2002 ◽  
Vol 38 (15) ◽  
pp. 1992-1997 ◽  
Author(s):  
N Androulakis ◽  
C Kouroussis ◽  
D Mavroudis ◽  
S Kakolyris ◽  
J Souglakos ◽  
...  

2009 ◽  
Vol 48 (1) ◽  
pp. 137-145 ◽  
Author(s):  
Svein Dueland ◽  
Steinar Aamdal ◽  
Michael J. Lind ◽  
Hilary Thomas ◽  
Marit Liland Sandvold ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document